These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31226663)

  • 21. Network Meta-analysis of the Benefit of Aspirin with Rivaroxaban vs. Clopidogrel for Patients with Stable Symptomatic Lower Extremity Arterial Disease.
    Ambler GK; Nordanstig J; Behrendt CA; Twine CP
    Eur J Vasc Endovasc Surg; 2021 Oct; 62(4):654-655. PubMed ID: 34452837
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?
    Fox KAA; Eikelboom JW; Anand SS; Bhatt DL; Bosch J; Connolly SJ; Harrington RA; Steg PG; Yusuf S
    Eur Heart J; 2019 May; 40(18):1466-1471. PubMed ID: 29945212
    [No Abstract]   [Full Text] [Related]  

  • 23. Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition.
    Ramacciotti E; Weitz JI
    Thromb Res; 2019 Dec; 184():44-49. PubMed ID: 31706067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: a practical approach.
    Arcelus JI; Domènech P; Fernández-Capitan Mdel C; Guijarro R; Jiménez D; Jiménez S; Lozano FS; Monreal M; Nieto JA; Páramo JA
    Clin Appl Thromb Hemost; 2015 May; 21(4):297-308. PubMed ID: 25504999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
    Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
    Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
    Weitz JI; Lensing AWA; Prins MH; Bauersachs R; Beyer-Westendorf J; Bounameaux H; Brighton TA; Cohen AT; Davidson BL; Decousus H; Freitas MCS; Holberg G; Kakkar AK; Haskell L; van Bellen B; Pap AF; Berkowitz SD; Verhamme P; Wells PS; Prandoni P;
    N Engl J Med; 2017 Mar; 376(13):1211-1222. PubMed ID: 28316279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rivaroxaban for thromboprophylaxis in a patient receiving electroconvulsive therapy.
    Shuman M; Hieber R; Moss L; Patel D
    J ECT; 2015 Mar; 31(1):e19-20. PubMed ID: 25587812
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.
    Shah R; Hellkamp A; Lokhnygina Y; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Fox KA; Nessel CC; Mahaffey KW; Piccini JP; Singer DE; Patel MR;
    Am Heart J; 2016 Sep; 179():77-86. PubMed ID: 27595682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rivaroxaban for Thromboprophylaxis After Nonelective Orthopedic Trauma Surgery in Switzerland.
    Hoffmeyer P; Simmen H; Jakob M; Sommer C; Platz A; Ilchmann T; Grossen E; Ryf C; Christofilopoulos P; Schueler M; Lassen MR; Rimle M; Gasser UE
    Orthopedics; 2017 Mar; 40(2):109-116. PubMed ID: 27874908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic influence of rivaroxaban on inflammation and coagulation biomarkers in patients with coronary artery disease and peripheral artery disease on aspirin therapy.
    Tantry U; Cummings C; Mackrell P; Gonze M; Ulloa K; Bafford R; Rout A; Sukhi A; Gurbel P
    Future Cardiol; 2020 Mar; 16(2):69-75. PubMed ID: 32129681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Single-Center, Randomized, Double-Blind Study of 94 Patients Undergoing Surgery for Cerebral Glioma to Compare Postoperative Thromboprophylaxis with and without Rivaroxaban.
    Wang ZY; Wan YD; Liu XZ; Wang H; Jiang GY; Yang B
    Med Sci Monit; 2022 Feb; 28():e934341. PubMed ID: 35140195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical management of rivaroxaban for the treatment of venous thromboembolism.
    Imberti D; Benedetti R
    Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor.
    Gomez D; Razmjou H; Donovan A; Bansal VB; Gollish JD; Murnaghan JJ
    J Arthroplasty; 2017 Mar; 32(3):958-964. PubMed ID: 27843040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Rivaroxaban Program and the Management of Unmet Needs in Thromboembolic Disease.
    Camm AJ
    Thromb Haemost; 2018 May; 118(S 01):S2-S11. PubMed ID: 29566415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
    Alzghari SK; Seago SE; Garza JE; Hashimie YF; Baty KA; Evans MF; Shaver C; Herrington JD
    J Oncol Pharm Pract; 2018 Oct; 24(7):494-500. PubMed ID: 28714376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locked Away: Percutaneous Closure of a Malignant Left Atrial Appendage to Constrain an Unresolvable Thrombus.
    Dugo D; Bordignon S; Konstantinou A; Perrotta L; Fürnkranz A; Chun JK; Schmidt B
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27489242
    [No Abstract]   [Full Text] [Related]  

  • 37. A treatment strategy using subcutaneous fondaparinux followed by oral rivaroxaban is effective for treating acute venous thromboembolism.
    Kabuki T; Nakanishi R; Hisatake S; Fujii T; Dobashi S; Wakakura S; Kiuchi S; Fujino T; Ikeda T
    J Cardiol; 2017 Aug; 70(2):163-168. PubMed ID: 27979674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An aspirin a day to keep the clots away: can aspirin prevent recurrent thrombosis in extended treatment for venous thromboembolism?
    Wakefield TW; Obi AT; Henke PK
    Circulation; 2014 Sep; 130(13):1031-3. PubMed ID: 25156993
    [No Abstract]   [Full Text] [Related]  

  • 39. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Ning GZ; Kan SL; Chen LX; Shangguan L; Feng SQ; Zhou Y
    Sci Rep; 2016 Mar; 6():23726. PubMed ID: 27020475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombosis prophylaxis after hip surgery- aspirin is not inferior to heparin].
    Markun S
    Praxis (Bern 1994); 2013 Oct; 102(21):1323-4. PubMed ID: 24129302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.